PTC Therapeutics Stock (NASDAQ: PTCT) stock price, news, charts, stock research, profile.
You can purchase shares of PTC Therapeutics (NASDAQ:PTCT) through any online brokerage.
Other companies in PTC Therapeutics’s space includes: Immunovant (NASDAQ:IMVT), Ultragenyx Pharmaceutical (NASDAQ:RARE), MoonLake (NASDAQ:MLTX), Alkermes (NASDAQ:ALKS) and SpringWorks Therapeutics (NASDAQ:SWTX).
PTC Therapeutics has a consensus price target of $41.58.
The stock price for PTC Therapeutics (NASDAQ: PTCT) is $43.94 last updated November 25, 2024 at 1:34 PM EST.
There are no upcoming dividends for PTC Therapeutics.
PTC Therapeutics’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for PTC Therapeutics.
PTC Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.